Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex.

Por Hodges, T L, Kahn, J O, Kaplan, L D, Groopman, J E, Volberding, P A, Amman, A J, Arri, C J, Bouvier, L M, Mordenti, J, Izu, A E
Publicado em 1991

Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 DNA Candidate Vaccine

Por Graham, Barney S., Koup, Richard A., Roederer, Mario, Bailer, Robert T., Enama, Mary E., Moodie, Zoe, Martin, Julie E., McCluskey, Margaret M., Chakrabarti, Bimal K., Lamoreaux, Laurie, Andrews, Charla A., Gomez, Phillip L., Mascola, John R., Nabel, Gary J.
Publicado em 2006

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

Por Cooper, David A., Heera, Jayvant, Ive, Prudence, Botes, Mariette, Dejesus, Edwin, Burnside, Robert, Clumeck, Nathan, Walmsley, Sharon, Lazzarin, Adriano, Mukwaya, Geoffrey, Saag, Michael, van Der Ryst, Elna
Publicado em 2014

A Phase 1 Randomized Placebo-Controlled Safety and Pharmacokinetic Trial of a Tenofovir Disoproxil Fumarate Vaginal Ring

Por Keller, Marla J., Mesquita, Pedro M., Marzinke, Mark A., Teller, Ryan, Espinoza, Lilia, Atrio, Jessica M., Lo, Yungtai, Frank, Bruce, Srinivasan, Sujatha, Fredricks, David N., Rabe, Lorna, Anderson, Peter L., Hendrix, Craig W., Kiser, Patrick F., Herold, Betsy C.
Publicado no AIDS (2016)

Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults

Por Harro, Clayton D., Robertson, Michael N., Lally, Michelle A., O'Neill, Lori D., Edupuganti, Srilatha, Goepfert, Paul A., Mulligan, Mark J., Priddy, Frances H., Dubey, Sheri A., Kierstead, Lisa S., Sun, Xiao, Casimiro, Danilo R., DiNubile, Mark J., Shiver, John W., Leavitt, Randi Y., Mehrotra, Devan V.
Publicado em 2009

... FAME‐04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics...

Por Bunge, Katherine E, Dezzutti, Charlene S, Hendrix, Craig W, Marzinke, Mark A, Spiegel, Hans M L, Moncla, Bernard J, Schwartz, Jill L, Meyn, Leslie A, Richardson‐Harman, Nicola, Rohan, Lisa C, Hillier, Sharon L
Publicado no J Int AIDS Soc (2018)

Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection

Por Rosenberg, Eric S., Graham, Barney S., Chan, Ellen S., Bosch, Ronald J., Stocker, Vicki, Maenza, Janine, Markowitz, Martin, Little, Susan, Sax, Paul E., Collier, Ann C., Nabel, Gary, Saindon, Suzanne, Flynn, Theresa, Kuritzkes, Daniel, Barouch, Dan H.
Publicado em 2010

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02(D) Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

Por Aide, Pedro, Aponte, John J., Renom, Montse, Nhampossa, Tacilta, Sacarlal, Jahit, Mandomando, Inacio, Bassat, Quique, Manaca, Maria Nélia, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Dubois, Marie-Claude, Loucq, Christian, Ballou, W. Ripley, Cohen, Joe, Alonso, Pedro L.
Publicado em 2010

Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India

Por Smita, Joshi, Soma, Dutta, Beverly, Bell, Albert, Profy, JoAnn, Kuruc, Fang, Gai, Missy, Cianciola, Lydia, Soto-Torres, Anjali, Panchanadikar, Arun, Risbud, Sanjay, Mehendale, Steven J, Reynolds
Publicado em 2006

RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study...

Por Anton, Peter A., Cranston, Ross D., Kashuba, Angela, Hendrix, Craig W., Bumpus, Namandjé N., Richardson-Harman, Nicola, Elliott, Julie, Janocko, Laura, Khanukhova, Elena, Dennis, Robert, Cumberland, William G., Ju, Chuan, Carballo-Diéguez, Alex, Mauck, Christine, McGowan, Ian
Publicado em 2012

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier...

Por M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov
Publicado em 2018-08-01

Safety of Regional 8-MHz Radiofrequency Capacitive Hyperthermia Combined with Magnetic Cationic Liposomes in Patients with Castration-Resistant Prostate Cancer: A Phase I Clinical Study

Por Noriyasu Kawai, Takeshi Kobayashi, Daichi Kobayashi, Kaname Tsutsumiuchi, Keitaro Iida, Toshiki Etani, Taku Naiki, Ryosuke Ando, Kentaro Mizuno, Atsushi Okada, Keiichi Tozawa, Takahiro Yasui
Publicado em 2016-12-01

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety...

Por Wesley de Jong, Joeri Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric van Gorp, Guido Vanham, Lorna Leal, Beatriz Mothe, Kris Thielemans, Montse Plana, Félipe Garcia, Rob Gruters, on behalf of the iHIVARNA consortium
Publicado em 2019-06-01

A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability...

Por Peck, Melicent, Rothenberg, Michael E., Deng, Rong, Lewin-Koh, Nicholas, She, Gaohong, Kamath, Amrita V., Carrasco-Triguero, Montserrat, Saad, Ola, Castro, Aide, Teufel, Lisa, Dickerson, Daniel S., Leonardelli, Marisa, Tavel, Jorge A.
Publicado no Antimicrob Agents Chemother (2019)

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

Por Qingsong Ye, Hua Wang, Xia Xia, Chenliang Zhou, Zhiming Liu, Zun-en Xia, Zhan Zhang, Yang Zhao, Jun Yehenala, Si Wang, Gangqiao Zhou, Ke Hu, Bin Wu, Chu-Tse Wu, Songling Wang, Yan He
Publicado em 2020-06-01

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I...

Por Mahomed, Sharana, Garrett, Nigel, Capparelli, Edmund, Baxter, Cheryl, Zuma, Nonhlanhla Yende, Gengiah, Tanuja, Archary, Derseree, Moore, Penny, Samsunder, Natasha, Barouch, Dan H, Mascola, John, Ledgerwood, Julie, Morris, Lynn, Abdool Karim, Salim
Publicado no BMJ Open (2019)

Menstrual cup use, leakage, acceptability, safety, and availability: a systematic review and meta-analysis

Por van Eijk, Anna Maria, Zulaika, Garazi, Lenchner, Madeline, Mason, Linda, Sivakami, Muthusamy, Nyothach, Elizabeth, Unger, Holger, Laserson, Kayla, Phillips-Howard, Penelope A
Publicado no Lancet Public Health (2019)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

Por Bhorat, As’ad E., Madhi, Shabir A., Laudat, France, Sundaraiyer, Vani, Gurtman, Alejandra, Jansen, Kathrin U., Scott, Daniel A., Emini, Emilio A., Gruber, William C., Schmoele-Thoma, Beate
Publicado no AIDS (2015)

Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women

Por Kahn, Jessica A., Xu, Jiahong, Kapogiannis, Bill G., Rudy, Bret, Gonin, René, Liu, Nancy, Wilson, Craig M., Worrell, Carol, Squires, Kathleen E.
Publicado em 2013

Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.

Por Goebel, F. D., Goldstein, D., Goos, M., Jablonowski, H., Stewart, J. S.
Publicado em 1996